Compounds > norfloxacin

norfloxacin and d-alpha tocopherol

norfloxacin has been researched along with d-alpha tocopherol in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Gibbons, S; Kaatz, GW; Zloh, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
He, Y; Liu, W; Mi, J; Sang, Z; Wu, A; Yang, J; Zhou, Y; Zhu, G1
Alba, MA; Gómez, JJ; Montoya-Estrada, A; Navarrete, JS; Paz, RF; Pérez, NJ; Sánchez, RR1
Naguib, MM; Valvano, MA1

Reviews

1 review(s) available for norfloxacin and d-alpha tocopherol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for norfloxacin and d-alpha tocopherol

ArticleYear
Inhibitors of multidrug resistance (MDR) have affinity for MDR substrates.
    Bioorganic & medicinal chemistry letters, 2004, Feb-23, Volume: 14, Issue:4

    Topics: Anti-Bacterial Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Biological Transport; Cell Membrane; Drug Resistance, Microbial; Drug Resistance, Multiple; Ligands; Models, Molecular

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of naringenin-O-carbamate derivatives as multi-target-directed liagnds for the treatment of Alzheimer's disease.
    Bioorganic & medicinal chemistry letters, 2022, 03-15, Volume: 60

    Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Butyrylcholinesterase; Carbamates; Cell Line; Cell Survival; Cholinesterase Inhibitors; Copper; Dose-Response Relationship, Drug; Drug Development; Flavanones; Humans; Molecular Structure; Neuroprotective Agents; Peptide Fragments; Protein Aggregates; Rats; Structure-Activity Relationship

2022
Comparative study of the antimutagenic properties of vitamins C and E against mutation induced by norfloxacin.
    BMC pharmacology, 2008, Feb-11, Volume: 8

    Topics: Animals; Anti-Bacterial Agents; Antimutagenic Agents; Ascorbic Acid; Biotransformation; Mutagenicity Tests; Mutagens; Mutation; Norfloxacin; Rats; Salmonella typhimurium; Vitamin E

2008
Vitamin E Increases Antimicrobial Sensitivity by Inhibiting Bacterial Lipocalin Antibiotic Binding.
    mSphere, 2018, 12-12, Volume: 3, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Burkholderia cenocepacia; Burkholderia Infections; Ceftazidime; Disease Models, Animal; Drug Therapy, Combination; Larva; Lepidoptera; Lipocalins; Microbial Sensitivity Tests; Norfloxacin; Survival Analysis; Vitamin E

2018